Skip to content

Vaginal Stump Infection After Laparoscopic Hysterectomy

Vaginal Stump Infection After Total Laparoscopic or Robot-assisted Hysterectomy

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04725981
Acronym
CoToIn
Enrollment
141
Registered
2021-01-27
Start date
2018-08-23
Completion date
2022-09-30
Last updated
2022-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laparoscopic Hysterectomy, Vaginal Infection

Keywords

vaginal closure technique

Brief summary

Comparing two surgical techniques in relation to vaginal stump infection, analysis of patient-based and therapy-based risk factors.

Detailed description

Comparing two surgical techniques for vaginal stump infection after total laparoscopic or robot-assisted hysterectomy. Analysis of patient-based and therapy-based risk factors with the aim of optimizing the surgical technique and objectifying the risk factors. Control group: old colpotomy technique (3 Z-sutures PDS 0); Intervention group: new colpotomy technique (3 Z sutures with PDS 0 and 1 continuous suture with V-Loc 2-0)

Interventions

PROCEDURETotal laparoscopic hysterectomy

Control group: colpotomy closure technique: 3 Z-sutures PDS 0 Intervention group: colpotomy closure technique: 3 Z sutures with PDS 0 and 1 continuous suture with V-Loc 2-0

Sponsors

University of Zurich
CollaboratorOTHER
Spital Limmattal Schlieren
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Intervention model description

Compare two surgical techniques Prospective randomized, controlled, single-blind inversion study

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Patient \> = 18 years old 2. Indication for total laparoscopic or robot-assisted hysterectomy 3. Benign uterine disease 4. Signed informed consent for study participation

Exclusion criteria

1. Patient with malignant gynecological diseases 2. Combination with other abdominal / vaginal interventions, except: * Adhesiolysis * Endometriosis removal (without rectovaginal endometriosis) * Conization * Hysteroscopy / curettage 3. Immunosuppressive therapy with cytostatics, glucocorticoids, HIV 4. Bleeding tendency / haemophilia 5. Acute infection

Design outcomes

Primary

MeasureTime frameDescription
Number of participants with vaginal stump infection in intervention group and control group6 weeks7.-10. day and 6 weeks postoperatively: 1. T ° C (fever\> = 38 ° C) 2. blood pressure (mm Hg) 3. general condition (good, reduced, bad) 4. Speculum examination / condition of the colpotomy: * non-irritating / intact * dehiscent * bleeding * fibrin-coated * purulent * tender * hyperemic * Infiltrated * Fistula formation 5. Lower abdominal pain (Visual Analog Scale (VAS): 0-10 6. transvaginal sonography: encapsulated RF on vaginal stump J: ☐N: ☐ 7. Laboratory CRP (\> 10mg / L) Hb (\<120 g / L) Lc ( \>10 G / L) The diagnosis of vaginal stump infection was made based on 2 of 3 positive clinical symptoms, 1 additional criterion and the corresponding sonographic findings. I. Clinical symptoms: 1. Fever\> = 38 ° C; 2. Dolence, redness, swelling, pus in the colpotomy area; 3. Lower abdominal pain ( VAS \>5) II. Sonographic signs (TVUS): encapsulated cystic mass on the vaginal stump Additional criteria: 1. CRP increased (\> 10mg / l); 2. Antibiotic therapy needs

Secondary

MeasureTime frameDescription
Identify of patient-based and treatment-based risk factors for vaginal stump infection.6 weeksconnection between Obesity ( BMI \>30 kg/ m2), nicotine abuse ( \>5 cigarettes/d), anemia ( Hb \<120g/L), operation time ( \>120min), uterine volume ( \>100 cm3) and appearance of vaginal stump infection

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026